Tigertriever for Stroke Recovery and Brain Function

Cognition and Imaging With Tigertriever

Recruiting Observational Study
Stroke
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Observational
Participants needed
424 (estimated)
Sponsor
Rapid Medical · Industry
Who this trial is looking for

This trial is looking for people who had a certain type of stroke and were treated with a device called Tigertriever. Participants will help researchers understand if using this device improves thinking skills after the stroke.

Are You a Good Fit for This Trial?
Rules you out Cerebral amyloid angiopathy

You may be able to join if

  • I have had a large vessel occlusion stroke and was treated with Tigertriever.
  • I am between 18 and 75 years old.
  • I have no major disability before my stroke.
  • I have signed the informed consent form.

You may not be able to join if

  • I received another device for my stroke before using Tigertriever.
  • I have bleeding in my brain as shown on CT or MRI.
  • I had a stroke or bleeding in my brain in the last 3 months.
  • I have been diagnosed with dementia or take medications for it.
  • I have depression that was diagnosed or treated before my stroke.
  • I have a learning or intellectual disability.
  • I will not be able to complete follow-up assessments in 6 months.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The objective of the COGNITIVE Study is to evaluate whether successful reperfusion with Tigertriever is associated with cognitive benefit.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patients admitted with large vessel occlusion (LVO) and treated with the Tigertriever, as indicated per the approved IFU. 2. Tigertriever was used as the first line treatment in the target vessel. 3. A signed informed consent. 4. Age 18-75 years (inclusive). 5. No known signi…
Contacts

Walid Haddad, Dr.

+972 72 2503331

walid@rapid-medical.com

CONTACT